Augmedix gains $23M in funding from McKesson Ventures, OrbiMed

Augmedix, a Google Glass startup, closed a $23 million round of funding from two new investors: McKesson Ventures and OrbiMed.

Advertisement

The other investors in this round include Redmile Group, Emergence Capital and DCM Ventures.

Since its founding in 2012, Augmedix has gained more than $60 million in funding from a variety of investors. In April, five major health systems and Augmedix customers — including Englewood, Colo.-based Catholic Health Initiatives, Sacramento, Calif.-based Sutter Health, Cincinnati-based TriHealth and San Francisco-based Dignity Health — invested in a $17 million funding round. The health systems did not invest in the most recent round.

Augmedix will use the $23 million from this round of funding to improve its platform and expand its service across the nation.

Healthcare providers can wear Google Glass while working with a patient, and Augmedix enables providers to retrieve the patient’s information without the use of a computer.

More articles on health IT:
Cerner president: We’re spending more on R&D than ever before
19 hospitals, health systems seeking Cerner, Meditech, Epic talent
KKR acquires Optiv Security

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Health IT

Advertisement

Comments are closed.